Home / Recalls / Akorn, Inc. / D-0814-2023

D-0814-2023 Class II Ongoing

Recalled by Akorn, Inc. — Gurnee, IL

Recall Details

Product Type
Drugs
Report Date
June 7, 2023
Initiation Date
April 26, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

Lactulose Solution, USP (Oral), 10g/15 mL, packaged in a) 15mL bottles, b) 30 mL bottles, c) 473 mL bottles, and d) 946 mL bottles, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL 60031. ALL NDCs

Reason for Recall

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Code Information

All Lots

Other recalls by Akorn, Inc.

  • D-0787-2023 Class II — Azelastine Hydrochloride Nasal Spray, 0.15%, 105.5 mcg per spray, Rx Only, For I (April 26, 2023)
  • D-0856-2023 Class II — XOPENEX (levalbuterol HCl) Inhalation Solution Concentrate, 1.25mg/3mL, 0.5 mL u (April 26, 2023)
  • D-0790-2023 Class II — Calcitriol Injection 1 mcg/mL, 1 mL ampules Rx Only, Distributed by: Akorn Opera (April 26, 2023)
  • D-0858-2023 Class II — Calcitriol Injection 2 mcg/mL, 1 mL ampules Rx Only, Distributed by: Akorn Opera (April 26, 2023)
  • D-0817-2023 Class II — Levocarnitine Oral Solution, USP, 118 mL bottles, Rx Only, Distributed by: Akorn (April 26, 2023)
  • D-0788-2023 Class II — AK-POLY-BAC (bacitracin Zinc and Polymyxin B Sulfate) Ophthalmic Ointment, 3.5g, (April 26, 2023)
  • D-0860-2023 Class II — Olopatadine HCl Ophthalmic Solution, USP, 0.2%, 5mL bottles, Rx Only, Sterile, M (April 26, 2023)
  • D-0861-2023 Class II — Pilocarpine Hydrochloride Ophthalmic Solution, USP 2%, 15 mL bottles, Rx Only, S (April 26, 2023)
  • D-0824-2023 Class II — Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100mL tubes, Rx (April 26, 2023)
  • D-0845-2023 Class II — Sodium Chloride Ophthalmic Solution, USP, 5%, 50mg/mL, 15 mL bottles, Distribute (April 26, 2023)